The program is part of a partnership between McMaster, Canadian Nuclear Laboratories (CNL) and Atomic Energy of Canada Limited (AECL) to advance nuclear research, education and training.
A mobile user experience lab designed to remove accessibility barriers will allow researchers to travel directly to participants who are typically underrepresented in research.
Fusion Pharmaceuticals’ new facility at McMaster Innovation Park (MIP) will support the research, development and production of next-generation radiopharmaceuticals for the treatment of various cancers.
McMaster logo
McMaster logo
